1. Home
  2. KZR vs MNDO Comparison

KZR vs MNDO Comparison

Compare KZR & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZR
  • MNDO
  • Stock Information
  • Founded
  • KZR 2015
  • MNDO 1995
  • Country
  • KZR United States
  • MNDO Israel
  • Employees
  • KZR N/A
  • MNDO N/A
  • Industry
  • KZR Biotechnology: Pharmaceutical Preparations
  • MNDO EDP Services
  • Sector
  • KZR Health Care
  • MNDO Technology
  • Exchange
  • KZR Nasdaq
  • MNDO Nasdaq
  • Market Cap
  • KZR 29.7M
  • MNDO 24.2M
  • IPO Year
  • KZR 2018
  • MNDO 2000
  • Fundamental
  • Price
  • KZR $3.83
  • MNDO $1.21
  • Analyst Decision
  • KZR Hold
  • MNDO
  • Analyst Count
  • KZR 2
  • MNDO 0
  • Target Price
  • KZR $9.00
  • MNDO N/A
  • AVG Volume (30 Days)
  • KZR 34.0K
  • MNDO 59.4K
  • Earning Date
  • KZR 08-13-2025
  • MNDO 08-11-2025
  • Dividend Yield
  • KZR N/A
  • MNDO 18.18%
  • EPS Growth
  • KZR N/A
  • MNDO N/A
  • EPS
  • KZR N/A
  • MNDO 0.15
  • Revenue
  • KZR N/A
  • MNDO $20,155,000.00
  • Revenue This Year
  • KZR N/A
  • MNDO N/A
  • Revenue Next Year
  • KZR N/A
  • MNDO N/A
  • P/E Ratio
  • KZR N/A
  • MNDO $8.00
  • Revenue Growth
  • KZR N/A
  • MNDO N/A
  • 52 Week Low
  • KZR $3.62
  • MNDO $1.02
  • 52 Week High
  • KZR $9.18
  • MNDO $2.13
  • Technical
  • Relative Strength Index (RSI)
  • KZR 39.10
  • MNDO 43.61
  • Support Level
  • KZR $3.84
  • MNDO $1.10
  • Resistance Level
  • KZR $4.10
  • MNDO $1.20
  • Average True Range (ATR)
  • KZR 0.14
  • MNDO 0.06
  • MACD
  • KZR 0.01
  • MNDO 0.01
  • Stochastic Oscillator
  • KZR 13.16
  • MNDO 72.00

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

Share on Social Networks: